The inverse epidemiological association between serum levels of HDL-C and risk of coronary artery disease (CAD) is graded and has been validated in multiple studies. However, there is remaining controversy whether a low HDL-C should not predominantly be considered a marker of poor lifestyle (obesity, lack of exercise, hypertriglyceridemia, diet, etc.), rather than a primary causal agent for…
Lifestyle and risk factor results show that recommended scientific guidelines form a contrast to what is achieved in daily practice in high risk individuals in primary prevention of CVD. Together with its partners the ESC demands a comprehensive and multisdicplinary primary prevention programme involving the high-risk population, their GP's and other health professionals, a health insurance…
The International Chair on Cardiometabolic Risk (ICCR) is pleased to announce the three winners of the European Media Prize co-sponsored by the ICCR and the Association of European Journalists (AEJ) and launched in November 2007 to reward articles that best inform readers about a growing public health issue: abdominal obesity and related risk of cardiovascular disease.
"Surgery should be performed using as often as possible surgical mitral valve repair, as this treatment has shown safety, efficacy and good long-term results," says French Prof Alec Vahanian on Monday, the third ESC day.
Transapical aortic valve implantation (TA-AVI) is a new therapeutic strategy, which has been implemented successfully into clinical practice in several hundred patients suffering symptomatic aortic stenosis and an increase perioperative risk during the past two years. The Edwards SAPIEN™ prosthesis has been used.
Catheter ablation is still associated with a substantial amount of complications, and more failure then sometimes reported. Perforation with catheters is especially important in atrial fibrillation. Robotic navigation could reduce these complications.
Since Rofecoxib (Vioxx) was withdrawn from the worldwide market based on the safety findings of the Adenomatous Polyp Prevention on Vioxx (APPROVe) study, the uncertainty around the cardiovascular safety of NSAIDs and COX-2 inhibitors remains and leaves practitioners with difficult management decisions for the hundreds of millions of patients worldwide who continue to require pain-relieving…
The Acuson SC2000 volume imaging ultrasound system - reported to be the first system in the world to acquire non-stitched real-time full-volume 3-D images of the heart in one single heart cycle - is launched at the ESC meeting in Munich.
The BACH (Biomarkers in Acute Congestive Heart Failure) trail, an international, multi-marker study, analysed the diagnostic and prognostic precision of new biomarkers in patients with dyspnea (Shortness of Breath).
Professor C Mueller adressed the issue of new biomarkers in acute cardiac care on the ESC on Monday, 1st September. Read his comment in the following.
Intima media thickness (IMT) is a valuable research tool that can be used as surrogate end points in clinical trails, says Professor Stefan Agewall.
Recent studies have shown that overweight and obesity during childhood and adolescence have a negative impact on the functioning of the internal walls of the arteries, paving the way to the development of an arteriosclerotic disease from an increasingly early age.
The diagnostic work-up of syncope patients often raises the question of how much diagnosis is necessary and what examination methods are really needed. To save time, specialists recommend focusing on determining whether the syncope may be caused by a cardiac problem - a question answered quite easily in many cases. Karl Eberius MD, European Hospital's new correspondent, discussed advice for…
This year sees the fifth anniversary of EuroPRevent.
The contraction of the atria and ventricles is differentially regulated, according to a study by Rodolphe Fischmeister and colleagues, at INSERM UMR-S 769 in Châtenay-Malabry.
An emerging discipline of noninvasive cardiac imaging, molecular imaging, has evolved constantly in the last few years and is increasingly being translated from the preclinical to the clinical level. Molecular imaging allows for unique insights into specific disease mechanisms and holds great promise to change the practice of cardiovascular medicine by facilitating early disease detection,…
Among the many aims of the Heart Failure Association of the ESC is the establishment of networks for the HF management, education and research.
St. Jude Medical, Inc. has received European CE Mark approval and US Food and Drug Administration (FDA) clearance for its Epicor LP cardiac ablation system, a second generation technology that uses HIFU (high intensity focused ultrasound) for surgical ablation of cardiac tissue to disrupt abnormal cardiac electrical impulses.
Cardiologist Dr Malissa Wood, of the Massachusetts General Hospital, Boston, USA, has reported that a study of Olympic athletes, using GE Healthcare's Vivid I cardiac compact ultrasound technology, has allowed the medical research team in Beijing to identify healthy patterns of heart enlargement that can differentiate it from hypertrophic cardiomyopathy.
The ageing population and growing risk factors have made a significant impact on driving up the number of registered heart failure (HF) cases. Existing pharmacological strategies are improving the survival rates of acute and early-stage HF patients, ironically providing a growing body of patients with progression of the disease to HF.
The world's first symposium on the molecular analysis of sudden death syndrome (SDS) among athletes drew in leading cardiovascular researchers and several top Spanish footballers. Sponsored by Applied Biosystems, and held in the Madrid's Hospital Clinico San Carolos, the I Symposium de Prevención en el Futbol aims to initiate the development of new tests to identify sports players at SDS risk.
A new educational website specifically for heart failure patients, their families and carers, has been set up by the Heart Failure Association of the European Society of Cardiology.
What is the role of vascular ultrasound in stroke prevention? Asked by Karoline Laarmann of European Hospital, Professor Christian Arning MD, Medical Director of the Neurology Department at Asklepios Klinik Wandsbek, Germany, and Deputy Chairman of the German Society of Ultrasound in Medicine (DEGUM), gave an unequivocal answer: crucial - but only if the sonographer is properly qualified.
Bad economic conditions, e.g. a recession, at the time of birth may lead to a higher risk of cardiovascular mortality much later in life, according to a recent study published by researchers at the Institute for the Study of Labour (IZA) in Bonn.
Syncope (fainting) is a leading cause of hospital emergency visits. In almost 10% of patients, syncope has a cardiac cause; in 50%, a non-cardiac cause, and in 40% the cause of syncope is unknown. Syncope is difficult to diagnose as syncopal episodes are often too infrequent and unpredictable for detection with conventional monitoring techniques.
